Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2024 Feb 6;149(6):484-486.
doi: 10.1161/CIRCULATIONAHA.123.067599. Epub 2023 Oct 24.

One-Year Outcomes After Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: A Prespecified Analysis of the SWISS-APERO Randomized Clinical Trial

Affiliations
Free article
Randomized Controlled Trial

One-Year Outcomes After Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: A Prespecified Analysis of the SWISS-APERO Randomized Clinical Trial

Roberto Galea et al. Circulation. .
Free article
No abstract available

Keywords: atrial fibrillation; ischemic stroke; left atrial appendage closure.

PubMed Disclaimer

Conflict of interest statement

Disclosures Dr Meneveau reports grants and personal fees from Bayer Healthcare, BMS Pfizer, and Abbott, as well as personal fees from Astra Zeneca and Terumo, outside the submitted work. Dr De Marco reports consultancies and paid expert testimonies from Abbott and Boston-Scientific. Dr Aminian is a proctor and consultant for Abbott and Boston-Scientific. Dr Chalkou reports a research grant from Janssen Switzerland (Johnson & Johnson). Dr Gräni reports funding from the Swiss National Science Foundation, InnoSuisse, CAIM foundation, GAMBIT foundation and Novartis foundation, outside of the submitted work. Dr Vranckx reports personal fees from AstraZeneca, Bristol Myers Squibb-Janssen, Bristol Myers Squibb-Pfizer, CSL Behring, and Daiichi-Sankyo, outside the submitted work. Dr Fischer reports grants from Medtronic and other from Medtronic, Stryker, and CSL-Behring, outside the submitted work. Dr Bedogni is a proctor for Abbott, Boston-Scientific, and Medtronic; he reports consultancies from Terumo and Meril. Dr Räber reports research grants to his institution from Abbott-Vascular, Boston-Scientific, Biotronik, Heartflow, and Sanofi, Regeneron. He reports speaker/consultation fees from Abbott-Vascular, Amgen, AstraZeneca, CSL-Behring, Canon, Occlutech, Sanofi, and Vifor. Dr Valgimigli has received grants and/or personal fees from AstraZeneca, Terumo, Alvimedica/CID, Abbott-Vascular, Daiichi-Sankyo, Opsens, Bayer, CoreFLOW, Idorsia-Pharmaceuticals-Ltd, Universität Basel Department Klinische Forschung, Vifor, Bristol-Myers-Squibb-SA, iVascular, and Medscape. The other authors report no conflicts.

Publication types

Associated data